{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-322704","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2025-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.654391+00:00","generated_at":"2026-05-16T12:51:35.571247+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"BioMarin appoints Rashmi Ramchandani as Chief Accounting Officer, effective Jan 19, 2026","bullets":["Ramchandani becomes VP, Chief Accounting Officer and principal accounting officer; CFO Brian Mueller remains principal financial officer.","Compensation: $460k base salary, $400k sign-on bonus, 45% target bonus, RSUs valued at $1.05M (4-year vest) and $400k (1-year cliff), options valued at $450k (4-year monthly vest).","She previously served as VP, Global Business Controller at Gilead Sciences and VP, Controller at Strava. Background includes Deloitte, Clorox, McKesson.","Sign-on bonus repayable if employment ends within two years for reasons other than job elimination, death, or disability."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-322704","json":"https://secwatch.observer/filing/0001193125-25-322704.json","markdown":"https://secwatch.observer/filing/0001193125-25-322704.md","text":"https://secwatch.observer/filing/0001193125-25-322704.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/0001193125-25-322704-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/d848371d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:51:35.571247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}